<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03197415</url>
  </required_header>
  <id_info>
    <org_study_id>RA-16025-RD-105064</org_study_id>
    <nct_id>NCT03197415</nct_id>
  </id_info>
  <brief_title>Platelet-rich Plasma for Low Back Pain</brief_title>
  <official_title>Intradiscal Injection of Platelet-rich Plasma for Discogenic Pain in L-spine</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pei-Yuan Lee, MD</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Aeon Biotechnology Corporation</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Show Chwan Memorial Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to evaluate the effect of platelet-rich plasma (PRP) on discogenic low back
      pain by comparing the pre- and post-interventional outcomes in patients receiving intradiscal
      injection of autologous PRP.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Intervertebral disc (IVD) degeneration is an important clinical problem that often
      contributes to low back pain and degenerative disc diseases. Degeneration of the IVD induces
      anulus tears and fissures, which can cause severe discogenic low back pain. Because the IVD
      has little potential to self-regenerate, treatment of degenerative disc disease is one of the
      most challenging clinical problems facing the spine surgeon. Platelet-rich plasma (PRP) is a
      fraction of plasma that contains platelets and multiple growth factors concentrated at high
      level. Because activated platelets have the potential to release growth factors, PRP has been
      clinically used to accelerate wound healing and tissue regeneration in orthopedic and oral
      surgery. The soluble releasate isolated from PRP has recently been demonstrated to influence
      the metabolism of intervertebral discs in vitro. Furthermore, an intradiscal injection of
      autologous PRP has been shown to induce restoration of structural changes in the rabbit
      annular injection model in vivo. This clinical trial aims to investigate the safety and
      efficacy of intradiscal PRP injection in patients with discogenic low back pain. The pre- and
      post-interventional imaging and clinical outcomes will be compared.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 22, 2016</start_date>
  <completion_date type="Anticipated">April 2018</completion_date>
  <primary_completion_date type="Anticipated">April 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>1-month postoperative function evaluated by Oswestry Disability Index</measure>
    <time_frame>1-month postoperative</time_frame>
    <description>Function is evaluated using Oswestry Disability Index.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>4-month postoperative function evaluated by Oswestry Disability Index</measure>
    <time_frame>4-month postoperative</time_frame>
    <description>Function is evaluated using Oswestry Disability Index</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>1-month postoperative pain evaluated by visual analogue scale</measure>
    <time_frame>1-month postoperative</time_frame>
    <description>Pain is evaluated using visual analogue scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>4-month postoperative pain evaluated by visual analogue scale</measure>
    <time_frame>4-month postoperative</time_frame>
    <description>Pain is evaluated using visual analogue scale</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Discogenic Pain</condition>
  <condition>Platelet-rich Plasma</condition>
  <arm_group>
    <arm_group_label>PRP group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intradisc injection of autologous platelet-rich plasma gel</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Platelet-rich plasma</intervention_name>
    <description>intradiscal injection of plasma-rich platelet</description>
    <arm_group_label>PRP group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age between 20 and 60 years

          -  L-spine disc degeneration diagnosed by MRI

          -  Low back pain

        Exclusion Criteria:

          -  Herniated disc

          -  With prior history of spine surgery

          -  With current or prior history of cancer

          -  With current or prior history of hematological disease

          -  Pregnancy

          -  Patients who will not cooperate with one-year followup
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pei-Yuan Lee, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Show Chwan Memorial Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ming-Hsien Hu, MD</last_name>
    <phone>+886-975611289</phone>
    <email>minghsienhu@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Show Chwan Memorial Hospital</name>
      <address>
        <city>Changhua City</city>
        <state>Changhua</state>
        <zip>500</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ming-Hsien Hu, MD</last_name>
      <phone>+886-975611289</phone>
      <email>minghsienhu@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 13, 2017</study_first_submitted>
  <study_first_submitted_qc>June 21, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 23, 2017</study_first_posted>
  <last_update_submitted>June 21, 2017</last_update_submitted>
  <last_update_submitted_qc>June 21, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 23, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Show Chwan Memorial Hospital</investigator_affiliation>
    <investigator_full_name>Pei-Yuan Lee, MD</investigator_full_name>
    <investigator_title>Superintendent</investigator_title>
  </responsible_party>
  <keyword>Platelet-rich plasma</keyword>
  <keyword>Intervertebral Disc Degeneration</keyword>
  <keyword>Low Back Pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Low Back Pain</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

